期刊文献+

金黄色葡萄球菌血流感染治疗失败的相关危险因素分析

Analysis on the Risk Factors Associated with the Failure of Treatment for Bloodstream Infection with Staphylococcus Aureus
下载PDF
导出
摘要 目的分析金黄色葡萄球菌血流感染治疗失败的相关危险因素。方法回顾性分析124例金黄色葡萄球菌血流感染患者的临床资料,以30 d作为判定治疗是否失败的节点,其中治疗失败组占33.87%(42/124),治疗成功组占66.13%(82/124);对比两组的性别、年龄、合并症、入住ICU、感染来源、感染来源危险分层、使用免疫抑制剂、2周内使用抗生素、发生感染性休克、早期治疗反应、APACHEⅡ评分、既往血培养阳性,并进行多因素Logistic回归分析。结果两组的年龄,合并糖尿病,入住ICU,感染来源于导管、肺炎及多来源,使用免疫抑制剂,2周内使用抗生素,发生感染性休克,早期治疗反应,APACHEⅡ评分,既往血培养阳性差异显著(P<0.05);多因素Logistic回归分析显示,多部位感染、发生感染性休克、既往血培养阳性和早期治疗反应均为金黄色葡萄球菌血流感染治疗失败的独立影响因素。结论金黄色葡萄球菌血流感染治疗失败的相关危险因素具有多样性,应根据患者是否存在多部位感染,及早进行血培养检查,评估感染性休克发生风险,观察早期治疗反应,综合评估治疗失败的风险,为临床治疗提供依据。 Objective To analyze the risk factors associated with the failure of treatment for bloodstream infection with staphylococ- cus aureus. Methods The clinical data of 124 patients with bloodstream infection with staphylococcus aureus were analyzed retrospectively. 30 d was used as the node to determine the failure of the treatment, all patients were divided into the successful treatment group (66.13%, 82/124) and the failed treatment group (33.87%, 42/124). The gender, age, comorbidities, admission to ICU, source of infection, source of infection risk stratification, use of immunosuppressive agents, use of antibiotics within 2 weeks, occurrence of septic shock, early treatment re- sponse, APACHE I1 score, and positive previous blood culture were compared between two groups, and multivariate Logistic regression analysis was made. Results The differences of age, complicated diabetes, admission to ICU, source of infection (catheter, pneumonia and multi-source), use of immunosuppressive agents, use of antibiotics within 2 weeks, occurrence of septic shock, early treatment response, A- PACHE II score, and positive previous blood culture between two groups were statistically significant (P〈0.05). Multivariate Logistic regres- sion analysis showed that, multi-site infection, occurrence of septic shock, positive previous blood culture and early treatment response were the independent factors of treatment failure for bloodstream infection with staphylococcus aureus. Conclusions The risk factors for treat- ment failure of bloodstream infection with staphylococcus aureus are diverse. According to whether there is multiple-site infection, early blood culture examination should be taken to assess the risk of occurrence of septic shock and to observe the early treatment response so as to have a comprehensive assessment of the risk of treatment failure, thus providing the basis for clinical treatment.
作者 郑思豪
出处 《临床医学工程》 2018年第2期251-252,共2页 Clinical Medicine & Engineering
关键词 金黄色葡萄球菌 血流感染 治疗失败 相关危险因素 Staphylococcus aureus Bloodstream infection Treatment failure Associated risk factors
  • 相关文献

参考文献5

二级参考文献29

  • 1Cosgrove SE, Carroll KC, Perl TM. Staphylococcus aureus with re- duced susceptibility to vancomycin[ J]. Clin infect Dis, 2004, 39 (4) : 539-545.
  • 2Cortes JA,Leal AL,Montanez AM,et al.Frequency of microorganisms isolated in patients with bacteremia in intensive care units in Colombia and their resistance profiles[J].Braz J Infect Dis,2013,17(3):346-52.
  • 3Harless K,Borlaug G,Monson TA,et al.An investigation of antibiotic susceptibility to empiric therapy for community-associated methicillin-resistant Staphylococcus aureus[J].WMJ,2014,113(2):59-63.
  • 4DENG Yan-yan, WANG Fang, TANG Zhi-jian, The distribu- tion and resistance of Staphylococcus aureus from bloodstream infection during 2011 to 2013[J]. Chin J Microeeol, 2014, 26 (7) : 829-830. (in Chinese).
  • 5Moore CL, Osaki-Kiyan P, Haque NZ, et al. Daptomycin ver- sus vancomycin for bloodstream infections due to methiciUin- resistant Staphylococcus aureus with a high vaneomycin mini- mum inhibitory concentration: A ease-control study[J]. Clin Infect Dis, 2012, 54(5): 51-58.
  • 6Boucher H, Miller LG, Razonable RR. Serious infections caused by methicillin-resistant Staphylococcus aureus [ J ]. Clin Infect Dis, 2010, 51(Supp12): S183-S197.
  • 7Jensen AG, Wachmann CH, Espersen F, et al. Treatment and outcome of Staphylococcus aureus bacteremia[J]. Arch Intern Med, 2002, 162(7): 25-32.
  • 8Joo J, Yamaki J, Lou M, et al. Early response assessment to guide management of methicillin-resistant Staphylococcus au- reus bloodstream infections with vaneomycin therapy[J]. Clin Therapeut, 2013, 35(7): 12-18.
  • 9Moore CL, Lu M, Cheema F, et al. Prediction of failure in vancomycin-treated methicillin-resistant Staphylococcus aureus bloodstream infection A clinically useful risk stratification tool [J]. Antimierob Agents& Chemother, 2011, 36 (5) 4581-4588.
  • 10Libert M, Elkholti M, Massaut J, et al. Risk factors for meti- cillin resistance and outcome of Staphylococcus aureus blood- stream infection in a belgian university hosp[J]. J Hosp In- fect, 2008, 68(1) 17-24.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部